Kent Shih, MD, on Adjuvant Therapy in Melanoma: How Does GEP Testing Factor In?

March 16, 2026 By The ASCO Post Staff

Kent Shih, MD, of Tennessee Oncology, presents three patients cases that show how the use of gene-expression profile testing guides patient and practitioner decision-making when choosing the appropriate path of adjuvant treatment among individuals with melanoma.

Related Content